• Bostom et al., 2011

    Bostom AG, et al.. Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation Trial. Circulation 2011; 123:17631770.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • Kuro-, 2011

    Kuro-O MA phosphate-centric paradigm for pathophysiology and therapy of chronic kidney disease. Kidney Int Suppl 2011; 3:420426.

Serum Phosphorus Affects Long-Term Kidney Transplant Outcomes

Restricted access

Serum phosphorus levels have a significant impact on outcomes after kidney transplantation—especially the risk of transplant failure, suggests a study in the American Journal of Kidney Diseases.

Despite a “marginal” effect on the risk of cardiovascular disease (CVD) events, higher phosphorus levels are associated with substantial increases in the risk of dialysis-dependent transplant failure and all-cause mortality, according to analysis of prospective data from a large sample of kidney transplant participants.

The study included data on more than 3000 kidney transplant participants enrolled in the “Folic Acid for Vascular Outcome Reduction in Transplantation” (FAVORIT) Trial—a randomized trial of